Published in Antimicrob Agents Chemother on April 01, 2001
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol (2004) 5.82
Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother (2001) 4.89
Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother (2003) 4.59
Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother (2002) 4.52
Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol (2001) 4.49
Global gene expression in Staphylococcus aureus biofilms. J Bacteriol (2004) 4.46
Persisters: a distinct physiological state of E. coli. BMC Microbiol (2006) 4.03
Candida biofilms: an update. Eukaryot Cell (2005) 3.58
The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. Appl Environ Microbiol (2001) 3.48
Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun (2002) 2.94
Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol (2005) 2.61
Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. J Clin Invest (2003) 2.54
Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun (2002) 2.32
Functional relationship between bacterial cell density and the efficacy of antibiotics. J Antimicrob Chemother (2009) 2.24
Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J Bacteriol (2006) 2.17
Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother (2003) 2.16
Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol Lett (2009) 2.05
Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J Bacteriol (2006) 2.04
Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proc Natl Acad Sci U S A (2008) 1.98
Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis. Infect Immun (2004) 1.84
Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy. Clin Microbiol Rev (2006) 1.82
Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother (2002) 1.76
Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection. Infect Immun (2006) 1.74
Characterization of monospecies biofilm formation by Helicobacter pylori. J Bacteriol (2004) 1.72
The exopolysaccharide matrix modulates the interaction between 3D architecture and virulence of a mixed-species oral biofilm. PLoS Pathog (2012) 1.72
Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media. Infect Immun (2006) 1.71
Application of a pH-sensitive fluoroprobe (C-SNARF-4) for pH microenvironment analysis in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol (2005) 1.67
GlpD and PlsB participate in persister cell formation in Escherichia coli. J Bacteriol (2006) 1.66
Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life. J Bacteriol (2004) 1.65
Fungal biofilms and drug resistance. Emerg Infect Dis (2004) 1.62
The Bvg virulence control system regulates biofilm formation in Bordetella bronchiseptica. J Bacteriol (2004) 1.60
Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection. Antimicrob Agents Chemother (2003) 1.56
Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile. Antimicrob Agents Chemother (2004) 1.55
Gentamicin promotes Staphylococcus aureus biofilms on silk suture. J Surg Res (2011) 1.53
Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. Methods Mol Biol (2007) 1.45
Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother (2003) 1.45
Biofilm formation by Candida dubliniensis. J Clin Microbiol (2001) 1.43
Effect of DNase and antibiotics on biofilm characteristics. Antimicrob Agents Chemother (2008) 1.42
Interactions between biocide cationic agents and bacterial biofilms. Antimicrob Agents Chemother (2002) 1.41
Effects of extracts from Italian medicinal plants on planktonic growth, biofilm formation and adherence of methicillin-resistant Staphylococcus aureus. J Ethnopharmacol (2008) 1.39
Antimicrobial peptides. Pharmaceuticals (Basel) (2013) 1.37
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother (2002) 1.36
Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol (2010) 1.35
Effect of growth in biofilms on chlorine susceptibility of Mycobacterium avium and Mycobacterium intracellulare. Appl Environ Microbiol (2006) 1.34
Structural and molecular basis of the role of starch and sucrose in Streptococcus mutans biofilm development. Appl Environ Microbiol (2008) 1.34
Growth phase-dependent expression of drug exporters in Escherichia coli and its contribution to drug tolerance. J Bacteriol (2006) 1.34
Antimicrobial photodynamic therapy combined with conventional endodontic treatment to eliminate root canal biofilm infection. Lasers Surg Med (2007) 1.33
Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother (2004) 1.31
Lessons learned and unlearned in periodontal microbiology. Periodontol 2000 (2013) 1.30
In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicrob Agents Chemother (2003) 1.28
Plastic biliary stent occlusion: factors involved and possible preventive approaches. Clin Med Res (2007) 1.26
Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob Agents Chemother (2007) 1.24
Hacking into bacterial biofilms: a new therapeutic challenge. Ann Intensive Care (2011) 1.23
Contribution of autolysin and Sortase a during Enterococcus faecalis DNA-dependent biofilm development. Infect Immun (2009) 1.23
Molecular mechanisms of multiple toxin-antitoxin systems are coordinated to govern the persister phenotype. Proc Natl Acad Sci U S A (2013) 1.22
A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes. Antimicrob Agents Chemother (2006) 1.22
Noninvasive biophotonic imaging for monitoring of catheter-associated urinary tract infections and therapy in mice. Infect Immun (2005) 1.20
A three-dimensional computer model of four hypothetical mechanisms protecting biofilms from antimicrobials. Appl Environ Microbiol (2006) 1.19
"Persisters": survival at the cellular level. PLoS Pathog (2011) 1.19
Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections. Infect Immun (2010) 1.19
Bistable expression of CsgD in biofilm development of Salmonella enterica serovar typhimurium. J Bacteriol (2009) 1.19
Listeria monocytogenes EGD-e biofilms: no mushrooms but a network of knitted chains. Appl Environ Microbiol (2008) 1.17
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother (2008) 1.17
Transmission electron microscopic study of antibiotic action on Klebsiella pneumoniae biofilm. Antimicrob Agents Chemother (2002) 1.17
Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother (2004) 1.17
Signal transduction, quorum-sensing, and extracellular protease activity in Enterococcus faecalis biofilm formation. J Bacteriol (2004) 1.17
Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev (2014) 1.16
Bacterial contamination of surgical suture resembles a biofilm. Surg Infect (Larchmt) (2010) 1.15
Use of in-biofilm expression technology to identify genes involved in Pseudomonas aeruginosa biofilm development. J Bacteriol (2003) 1.14
Attenuated virulence and biofilm formation in Staphylococcus aureus following sublethal exposure to triclosan. Antimicrob Agents Chemother (2012) 1.13
Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob Agents Chemother (2008) 1.13
Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One (2010) 1.13
Analysis of bacterial biofilms using NMR-based metabolomics. Future Med Chem (2012) 1.11
Interrelationships between colonies, biofilms, and planktonic cells of Pseudomonas aeruginosa. J Bacteriol (2007) 1.11
Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother (2011) 1.10
Pseudomonas aeruginosa, Candida albicans, and device-related nosocomial infections: implications, trends, and potential approaches for control. J Ind Microbiol Biotechnol (2005) 1.10
B cell activation by outer membrane vesicles--a novel virulence mechanism. PLoS Pathog (2010) 1.09
Mutation of traP in Staphylococcus aureus has no impact on expression of agr or biofilm formation. Infect Immun (2007) 1.09
Natural genetic transformation in monoculture Acinetobacter sp. strain BD413 biofilms. Appl Environ Microbiol (2003) 1.09
Biofilm formation by group a streptococci: is there a relationship with treatment failure? J Clin Microbiol (2003) 1.08
Ultrasonic-enhanced gentamicin transport through colony biofilms of Pseudomonas aeruginosa and Escherichia coli. J Infect Chemother (2004) 1.08
Could Histoplasma capsulatum Be Related to Healthcare-Associated Infections? Biomed Res Int (2015) 1.07
Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol (2012) 1.07
Flagellated but not hyperfimbriated Salmonella enterica serovar Typhimurium attaches to and forms biofilms on cholesterol-coated surfaces. J Bacteriol (2010) 1.06
Survival of Vibrio cholerae in nutrient-poor environments is associated with a novel "persister" phenotype. PLoS One (2012) 1.06
Role of silver ions in destabilization of intermolecular adhesion forces measured by atomic force microscopy in Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother (2005) 1.05
All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease. Virulence (2011) 1.05
Phenotypic diversification and adaptation of Serratia marcescens MG1 biofilm-derived morphotypes. J Bacteriol (2006) 1.04
Biocidal efficacy, biofilm-controlling function, and controlled release effect of chloromelamine-based bioresponsive fibrous materials. Biomaterials (2006) 1.03
Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis. Infect Immun (2005) 1.03
Planktonic aggregates of Staphylococcus aureus protect against common antibiotics. PLoS One (2012) 1.02
The urinary antibiotic 5-nitro-8-hydroxyquinoline (Nitroxoline) reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc. Antimicrob Agents Chemother (2012) 1.02
Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond. Curr Opin Pharmacol (2013) 1.02
Purification and Characterization of Biofilm-Associated EPS Exopolysaccharides from ESKAPE Organisms and Other Pathogens. PLoS One (2013) 1.01
Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. PLoS One (2013) 1.01
Assessment of the roles of LuxS, S-ribosyl homocysteine, and autoinducer 2 in cell attachment during biofilm formation by Listeria monocytogenes EGD-e. Appl Environ Microbiol (2006) 1.00
Inhibitory effects of 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose on biofilm formation by Staphylococcus aureus. Antimicrob Agents Chemother (2010) 0.99
The potential of antimicrobial peptides as biocides. Int J Mol Sci (2011) 0.99
Secretion of proteases by Pseudomonas aeruginosa biofilms exposed to ciprofloxacin. Antimicrob Agents Chemother (2005) 0.99
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science (1998) 19.92
Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol (1998) 17.38
Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol (1998) 17.18
Biofilm formation as microbial development. Annu Rev Microbiol (2000) 13.33
Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science (1994) 11.18
Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol (1998) 10.07
Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature (1970) 9.07
The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol (1999) 7.19
Genetic approaches to study of biofilms. Methods Enzymol (1999) 6.78
Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 6.65
Steps in the development of a Vibrio cholerae El Tor biofilm. Mol Microbiol (1999) 6.06
Emr, an Escherichia coli locus for multidrug resistance. Proc Natl Acad Sci U S A (1992) 5.30
hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol (1983) 4.59
Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother (2000) 4.41
Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob Agents Chemother (1996) 3.60
Programmed death in bacteria. Microbiol Mol Biol Rev (2000) 3.49
Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature (1999) 3.41
Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol Microbiol (1999) 2.95
A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother (2000) 2.91
Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci U S A (2000) 2.71
Biofilm susceptibility to antimicrobials. Adv Dent Res (1997) 2.59
Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother (2000) 2.55
Molecular cloning and expression of hipA, a gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol (1986) 2.50
Extracellular products as mediators of the formation and detachment of Pseudomonas fluorescens biofilms. FEMS Microbiol Lett (1998) 2.46
Nonspecific adherence by Actinobacillus actinomycetemcomitans requires genes widespread in bacteria and archaea. J Bacteriol (2000) 2.46
Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol (2000) 2.41
Role of alginate lyase in cell detachment of Pseudomonas aeruginosa. Appl Environ Microbiol (1994) 2.40
Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J Bacteriol (1991) 2.37
Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J Bacteriol (1994) 2.33
Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol (1999) 2.32
Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet (1998) 2.19
Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J Med Chem (1999) 2.10
Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrob Agents Chemother (1991) 2.09
Protective role of catalase in Pseudomonas aeruginosa biofilm resistance to hydrogen peroxide. Appl Environ Microbiol (1999) 1.99
The biofilm glycocalyx as a resistance factor. J Antimicrob Chemother (1990) 1.98
Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents. Antimicrob Agents Chemother (1990) 1.97
Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob Agents Chemother (1998) 1.92
Conditional impairment of cell division and altered lethality in hipA mutants of Escherichia coli K-12. J Bacteriol (1988) 1.90
Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. Chemotherapy (1997) 1.74
Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob Agents Chemother (1999) 1.74
Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli. J Antimicrob Chemother (1994) 1.58
New aspects in the molecular basis of polymer-associated infections due to staphylococci. Eur J Clin Microbiol Infect Dis (1999) 1.57
A rapid screening procedure to identify mini-Tn10 insertion mutants of Escherichia coli K-12 with altered adhesion properties. FEMS Microbiol Lett (1996) 1.49
Effect of laminar flow velocity on the kinetics of surface recolonization by Mot(+) and Mot (-) Pseudomonas fluorescens. Microb Ecol (1989) 1.49
Purification and ligand binding of EmrR, a regulator of a multidrug transporter. J Bacteriol (1999) 1.48
Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics. Antimicrob Agents Chemother (1997) 1.46
Direct correlation between overproduction of guanosine 3',5'-bispyrophosphate (ppGpp) and penicillin tolerance in Escherichia coli. J Bacteriol (1995) 1.45
Effect of Motility on Surface Colonization and Reproductive Success of Pseudomonas fluorescens in Dual-Dilution Continuous Culture and Batch Culture Systems. Appl Environ Microbiol (1994) 1.41
In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob Agents Chemother (1998) 1.36
Pulsed ultrasound enhances the killing of Escherichia coli biofilms by aminoglycoside antibiotics in vivo. Antimicrob Agents Chemother (2000) 1.29
Intravascular catheters impregnated with antimicrobial agents: a milestone in the prevention of bloodstream infections. Support Care Cancer (1999) 1.25
Signal transduction by a death signal peptide: uncovering the mechanism of bacterial killing by penicillin. Mol Cell (2000) 1.23
Bactericidal activities of five quinolones for Escherichia coli strains with mutations in genes encoding the SOS response or cell division. Antimicrob Agents Chemother (1992) 1.23
An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms. J Antimicrob Chemother (2000) 1.17
Robbins device in biofilm research. Methods Enzymol (1999) 1.15
Control of the activity of the soluble lytic transglycosylase by the stringent response in Escherichia coli. FEMS Microbiol Lett (1990) 1.15
The role of pili in the attachment of Pseudomonas aeruginosa to unworn hydrogel contact lenses. Curr Eye Res (1993) 1.14
Enhanced bacterial biofilm control using electromagnetic fields in combination with antibiotics. Methods Enzymol (1999) 1.12
Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology (1999) 1.10
Synthesis and characterization of a novel biodegradable antimicrobial polymer. Biomaterials (2000) 1.02
The growth of Gardnerella vaginalis and Lactobacillus acidophilus in Sorbarod biofilms. J Med Microbiol (1998) 0.99
Hydrophobic bile salt inhibits bacterial adhesion on biliary stent material. Dig Dis Sci (1994) 0.94
Novel methods for the prevention of infection of intravascular devices. J Hosp Infect (1999) 0.90
Evaluation of experimental therapeutics in a new mouse model of Helicobacter felis utilizing 16S rRNA polymerase chain reaction for detection. Scand J Gastroenterol (1997) 0.85
Studying initial phase of biofilm formation: molecular interaction of host proteins and bacterial surface components. Methods Enzymol (1999) 0.85